Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Ting Chuang
Treatment With a New Benzimidazole Derivative Bearing a Pyrrolidine Side Chain Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
Related publications
TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity
Internal Medicine
Internal Medicine
Medicine
The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Pcn168 - Cost-Effectiveness of Sorafenib in the Treatment of Hepatocellular Carcinoma: A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
M2 Macrophages Mediate Sorafenib Resistance by Secreting HGF in a Feed-Forward Manner in Hepatocellular Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Sorafenib Treatment in Advanced Hepatocellular Carcinoma With Tumor Thrombus Nearly Occupying the Entire Right Atrium
Journal of Liver Cancer
